These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4084670)

  • 1. Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration.
    Arnold TH; Tackett RL; Vallner JJ
    Biopharm Drug Dispos; 1985; 6(4):447-54. PubMed ID: 4084670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in the pharmacodynamics of verapamil.
    Arnold TH; Vallner JJ; Tackett RL
    Am Heart J; 1985 Nov; 110(5):981-5. PubMed ID: 4061274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
    McAllister RG; Bourne DW; Dittert LW
    J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intranasal versus intravenous verapamil bioavailability.
    Watling S; Engelhardt J; Kandrotas R; Gal P; Kroboth P; Smith H; Johnson M
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):100-4. PubMed ID: 8458675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.
    Barbarash RA; Bauman JL; Fischer JH; Kondos GT; Batenhorst RL
    Chest; 1988 Nov; 94(5):954-9. PubMed ID: 3180898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of verapamil in man.
    Koike Y; Shimamura K; Shudo I; Saito H
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):37-47. PubMed ID: 432439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal absorption of procyclidine in rats and dogs.
    Jang EJ; Lee YJ; Chung SJ; Shim CK
    Arch Pharm Res; 2001 Jun; 24(3):219-23. PubMed ID: 11440081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of meclizine levels in the plasma of rats and dogs after intranasal, intravenous, and oral administration.
    Chovan JP; Klett RP; Rakieten N
    J Pharm Sci; 1985 Oct; 74(10):1111-3. PubMed ID: 4078711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.
    John DN; Fort S; Lewis MJ; Luscombe DK
    Br J Clin Pharmacol; 1992 Jun; 33(6):623-7. PubMed ID: 1389935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of verapamil elimination kinetics during chronic oral administration.
    Schwartz JB; Keefe DL; Kirsten E; Kates RE; Harrison DC
    Am Heart J; 1982 Aug; 104(2 Pt 1):198-203. PubMed ID: 7102502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronopharmacology of intravenous and oral modified release verapamil.
    Dilger K; Eckhardt K; Hofmann U; Kucher K; Mikus G; Eichelbaum M
    Br J Clin Pharmacol; 1999 Apr; 47(4):413-9. PubMed ID: 10233206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P; BondessoN U; Sylvén C
    Eur J Clin Pharmacol; 1982; 23(1):49-57. PubMed ID: 7128672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of DGAVP in plasma following intranasal and oral administration to healthy subjects.
    Westenberg HG; Hijman R; Wiegant VM; Laczi F; Van Ree JM
    Peptides; 1994; 15(6):1101-4. PubMed ID: 7991455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.